PeriOperative Medicine - Metabolic Inflexibility as a Mechanism for Myocardial Injury After Non-Cardiac Surgery
POM-MIMICS
3 other identifiers
observational
300
0 countries
N/A
Brief Summary
The goal of this observational study is to learn whether metabolic inflexibility, which means reduced ability of the body to switch between using fats and sugars for energy, is associated with myocardial injury after non-cardiac surgery (MINS) in adults undergoing major elective abdominal cancer surgery. The main question it aims to answer is: Does pre-operative metabolic inflexibility predict myocardial injury after non-cardiac surgery (MINS) within the first 72 hours after surgery? Participants will continue with their usual surgical care and pre-planned CPET (which can measure metabolic flexibility). As part of the study, participants will:
- Have additional blood samples taken before and after surgery
- Have an echocardiogram and, where possible, muscle ultrasound
- Wear a wrist-worn activity monitor before surgery
- Have routine clinical and surgical information collected from their medical records
- Receive a follow-up phone call around 90 days after surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2026
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 25, 2026
CompletedFirst Posted
Study publicly available on registry
July 10, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2030
Study Completion
Last participant's last visit for all outcomes
October 1, 2030
July 14, 2026
July 1, 2026
4 years
June 25, 2026
July 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Development of Myocardial Injury after Non-Cardiac Surgery
The primary outcome is the number of participants who develop myocardial injury after non-cardiac surgery (MINS) within 72 hours after surgery. MINS means evidence of heart muscle injury after an operation that is not heart surgery. It will be assessed using blood tests for high-sensitivity cardiac troponin I, a protein that is released into the blood when the heart muscle is injured. Blood samples will be taken on postoperative days 1, 2, and 3. Participants will be classified as having MINS if their postoperative troponin result is above the study-defined threshold for myocardial injury and the injury is judged to be related to the perioperative period rather than another clear non-surgical cause.
From surgery to 72 hours post surgery
Secondary Outcomes (4)
Clavien-Dindo Complication Grade
From surgery to 30 days after surgery
Post-Operative Morbidity Survey (POMS)
Postoperative day 7
Length of Hospital Stay
From surgery up to hospital discharge, an expected average of 7 days after surgery
Days Alive and Out of Hospital at 90 Days
From surgery to 90 days after surgery
Study Arms (1)
Major Abdominal Cancer Surgery Cohort
Adults aged 18 years and over who are scheduled to undergo major elective abdominal cancer surgery and are already referred for routine pre-operative cardiopulmonary exercise testing (CPET). This is an observational cohort study; no study-specific treatment or intervention will be assigned. Participants will continue with their usual surgical and perioperative care. The study will collect additional blood samples, imaging assessments, CPET-derived metabolic data, wearable activity data, and routine clinical information to evaluate whether pre-operative metabolic inflexibility is associated with myocardial injury after non-cardiac surgery.
Interventions
Pre-operative metabolic inflexibility will be assessed as an observational exposure using data from routine pre-operative cardiopulmonary exercise testing (CPET). CPET-derived measures of substrate utilisation, including fat and carbohydrate oxidation, will be used to evaluate the participant's ability to switch between energy sources during physiological stress. Additional blood-based metabolic, immune, and cardiac biomarker analyses may be used to further characterise metabolic phenotype. No treatment, procedure, or clinical management will be assigned or altered by the study.
Eligibility Criteria
Participants will be selected from patients receiving care at University College London Hospitals and other participating CIPHER-2 network hospitals, including Southampton and Plymouth. Potential participants will be identified through perioperative/pre-operative assessment pathways, including routine cardiopulmonary exercise testing clinics for patients being assessed before major surgery.
You may qualify if:
- Adults aged 18 or over
- Scheduled for major elective abdominal cancer surgery with planned overnight admission
- Scheduled for pre-operative CPET
- Able to provide written informed consent
You may not qualify if:
- Less than 18 years old
- Emergency surgery
- Unable or unwilling to undergo CPET
- Pregnancy
- Active sepsis
- End-stage organ failure (e.g. on dialysis)
- Participants without the mental capacity to consent
- Diagnosis of Type 1 Myocardial Infarction meeting the 4th Universal Definition criteria during the immediate pre-operative period. (Note: Added based on MINS definition context)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Blood samples will be retained. These may include plasma, serum, and peripheral blood mononuclear cell (PBMC) samples collected before and after surgery.
Study Officials
- PRINCIPAL INVESTIGATOR
John Whittle, MBBS, PhD
University College, London
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 25, 2026
First Posted
July 10, 2026
Study Start (Estimated)
October 1, 2026
Primary Completion (Estimated)
October 1, 2030
Study Completion (Estimated)
October 1, 2030
Last Updated
July 14, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be made publicly available. The study involves clinical data and blood-derived biomarker data from patients undergoing cancer surgery, and data sharing is restricted by participant confidentiality, consent, and data protection requirements. Results will be reported in aggregate form so that individual participants cannot be identified.